Skip to main content
. 2022 May 24;62(2):794–803. doi: 10.1093/rheumatology/keac312

Table 3.

Demographic data for CAPS participants included and excluded from the current study

Characteristics Included (n = 182) Included, %/median (IQR) Excluded (n = 820) Excluded, %/median (IQR)
Gender Male 74 41 345 42
Female 108 59 475 58
Age at onset, years 5–10 101 55 306 37
≥11 40 22 250 31
Missing or <5 41 22 264 32
Overall 153 8.8 (6.6–11.1) 602 10.2 (7–12.5)
JIA subtype Systemic arthritis 8 4 55 7
Persistent oligoarthritis 75 41 292 36
Extended oligoarthritis 7 4 17 2
Polyarthritis (RF−) 27 15 131 16
Polyarthritis (RF+) 6 3 31 4
ERA 12 7 58 7
Psoriatic arthritis 15 8 68 8
Unclassifiable JIA 32 18 110 13
Other inflammatory arthritis 0 0 30 4
ILAR missing 0 0% 26 3%
Core outcome variables CHAQ 164 0.625 (0.125–1.375) 451 0.625 (0.125–1.25)
Parent VAS 164 16.5 (4–49) 409 24 (5–50)
Physician VAS 144 30 (16–53) 502 28 (15–49)
Active joint count 165 2 (1–6) 611 2 (1–5)
Limited joint count 165 1 (1–4) 611 1 (0–4)
ESR 101 19 (7–44) 464 20 (7–50)